DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Ghazzi MN, Perez JE, Antonucci TK et al.
Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group.
Diabetes 1997;
46 (03) 433-439
http://www.ncbi.nlm.nih.gov/pubmed/9032099
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.